Prevymis (letermovir) - Merck (MSD)
Something old, something new? Herpesvirus genome packaging examined in light of lessons from the tailed bacteriophages. (PubMed, J Virol) - Jul 7, 2026 - "The success of letermovir, a first-in-class human cytomegalovirus genome packaging inhibitor, suggests that this critical step in the virus life cycle can be targeted in other herpesvirus infections. Here, we integrate recent structural, biophysical, and genetic information from representative dsDNA viruses to define the overarching principles of viral genome packaging and highlight evolutionary distinctions. What lessons can we learn from bacteriophages to further our understanding of herpesvirus packaging, and can these insights generate new opportunities for antiherpesvirus therapeutics?" 
Journal • Review • Cytomegalovirus Infection • Infectious Disease
http://www.ncbi.nlm.nih.gov/pubmed/42405778
 
Allison L Didychuk; Elizabeth J Bailey; Jamie V Shiah; Laura M Meißner; Olaide A Adeyemi; Sara Gelles-Watnick
 
Jul 7, 2026
 
Prev Next